发布求助
文献互助 智能选刊 最新文献

Colorectal Cancer最新文献

筛选
英文 中文
Tumor immune microenvironment and response of immunotherapy in patients with colorectal cancer 肿瘤免疫微环境与结直肠癌患者对免疫疗法的反应
IF 2.7
Colorectal Cancer Pub Date : 2024-07-16 DOI: 10.1080/1758194x.2024.2370228
Qiulin Liao, Shuiping Jing, Yueyuan Liao, Qichun Cai, Hongyu Zhang, Dayun Peng, Zhenlian Li
{"title":"Tumor immune microenvironment and response of immunotherapy in patients with colorectal cancer","authors":"Qiulin Liao, Shuiping Jing, Yueyuan Liao, Qichun Cai, Hongyu Zhang, Dayun Peng, Zhenlian Li","doi":"10.1080/1758194x.2024.2370228","DOIUrl":"https://doi.org/10.1080/1758194x.2024.2370228","url":null,"abstract":"","PeriodicalId":43638,"journal":{"name":"Colorectal Cancer","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2024-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141643745","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Time interval between neoadjuvant radiation therapy and surgery and overall survival of rectal cancer patients 新辅助放疗与手术之间的时间间隔与直肠癌患者的总生存率
IF 4.2
Colorectal Cancer Pub Date : 2024-06-07 DOI: 10.1080/1758194x.2024.2354650
S. Amin, M. Patel, Chi Lin
{"title":"Time interval between neoadjuvant radiation therapy and surgery and overall survival of rectal cancer patients","authors":"S. Amin, M. Patel, Chi Lin","doi":"10.1080/1758194x.2024.2354650","DOIUrl":"https://doi.org/10.1080/1758194x.2024.2354650","url":null,"abstract":"","PeriodicalId":43638,"journal":{"name":"Colorectal Cancer","volume":null,"pages":null},"PeriodicalIF":4.2,"publicationDate":"2024-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141370899","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Biological sex and chemotherapy treatment delays in patients with colorectal cancer 结直肠癌患者的生物性别与化疗延迟
IF 4.2
Colorectal Cancer Pub Date : 2024-06-07 DOI: 10.1080/1758194x.2024.2352410
P. Chambers, Anna D. Wagner, Ofran Almossawi, Simon Jenkinson, Gabriel A Brooks, John Bridgewater
{"title":"Biological sex and chemotherapy treatment delays in patients with colorectal cancer","authors":"P. Chambers, Anna D. Wagner, Ofran Almossawi, Simon Jenkinson, Gabriel A Brooks, John Bridgewater","doi":"10.1080/1758194x.2024.2352410","DOIUrl":"https://doi.org/10.1080/1758194x.2024.2352410","url":null,"abstract":"","PeriodicalId":43638,"journal":{"name":"Colorectal Cancer","volume":null,"pages":null},"PeriodicalIF":4.2,"publicationDate":"2024-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141374392","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The role of colorectal cancer plasticity in metastasis and treatment: an interview with Mirjana Efremova 大肠癌可塑性在转移和治疗中的作用：对 Mirjana Efremova 的采访
IF 4.2
Colorectal Cancer Pub Date : 2023-12-01 DOI: 10.2217/crc-2023-0015
Mirjana Efremova
{"title":"The role of colorectal cancer plasticity in metastasis and treatment: an interview with Mirjana Efremova","authors":"Mirjana Efremova","doi":"10.2217/crc-2023-0015","DOIUrl":"https://doi.org/10.2217/crc-2023-0015","url":null,"abstract":"Mirjana Efremova speaks to Megan Bryant, Journal Development Editor for Colorectal Cancer at the 4th International Cancer Conference at the CRICK Institute about her research into how colorectal cells adapt and change through plasticity.","PeriodicalId":43638,"journal":{"name":"Colorectal Cancer","volume":null,"pages":null},"PeriodicalIF":4.2,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139015222","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic significance of the diameter of superior rectal vein for locally advanced rectal cancer 直肠上静脉直径对局部晚期直肠癌预后的意义
Colorectal Cancer Pub Date : 2023-11-09 DOI: 10.2217/crc-2023-0004
Yafang Hong, Anchuan Li, Runfan Chen, Benhua Xu
{"title":"Prognostic significance of the diameter of superior rectal vein for locally advanced rectal cancer","authors":"Yafang Hong, Anchuan Li, Runfan Chen, Benhua Xu","doi":"10.2217/crc-2023-0004","DOIUrl":"https://doi.org/10.2217/crc-2023-0004","url":null,"abstract":"Aim: To evaluate the association between the diameter of the superior rectal vein (dSRV) and prognosis in patients with locally advanced rectal cancer (LARC). Methods: This study included 420 LARC patients. Kaplan-Meier survival analysis and Cox regression models were used for determining the relationship between superior rectal vein diameter and survival. Results: Patients whose dSRV >3.60 mm had better 3 years disease-free survival (85.50 vs 64.2%, p < 0.001) and overall survival (91.90 vs 82.20%, p = 0.005). The multivariate Cox regression analysis showed that the dSRV was an independent prognostic factor for survival. Conclusion: The dSRV measurement is valuable in predicting the prognosis of patients with LARC, and the prognosis of patients with a smaller dSRV seems to be poor.","PeriodicalId":43638,"journal":{"name":"Colorectal Cancer","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135286124","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical and quality of life outcomes with trifluridine/tipiracil: PRECONNECT and TALLISUR studies 三氟吡啶/替吡拉西的临床和生活质量结果：PRECONNECT和TALLISUR研究
IF 4.2
Colorectal Cancer Pub Date : 2023-08-17 DOI: 10.2217/crc-2022-0013
L. Wyrwicz, J. Taieb, T. Price, J. Bachet, M. Karthaus, L. Vidot, Bénédicte Chevallier, T. Reisländer, L. Weiss, V. Heinemann
{"title":"Clinical and quality of life outcomes with trifluridine/tipiracil: PRECONNECT and TALLISUR studies","authors":"L. Wyrwicz, J. Taieb, T. Price, J. Bachet, M. Karthaus, L. Vidot, Bénédicte Chevallier, T. Reisländer, L. Weiss, V. Heinemann","doi":"10.2217/crc-2022-0013","DOIUrl":"https://doi.org/10.2217/crc-2022-0013","url":null,"abstract":"Background: QLQ-C30 Global Health Status (GHS) and Eastern Cooperative Oncology Group performance status (ECOG PS) data from PRECONNECT and TALLISUR studies were pooled. Materials & methods: Association between changes in ECOG PS and QLQ-C30 GHS in patients with metastatic colorectal cancer (mCRC) receiving trifluridine/tipiracil (FTD/TPI) was evaluated using Cox regression analysis. Results: 1100 patients were included. There was no clinically relevant change from baseline in QLQ-C30 GHS score through cycle 7. 63.0% of patients maintained/improved ECOG PS. The presence of liver metastasis increased the risk of QLQ-C30 GHS score/ECOG PS deterioration. The association between time to ECOG PS deterioration and change in QLQ-C30 GHS score over time was significant (HR 1.71 [95% CI: 1.4, 2.2]). Conclusion: ECOG PS and QLQ-C30 GHS scores were maintained during FTD/TPI treatment, and these measures were associated. Factors that increased the risk of deterioration included the presence of liver/lung metastasis, younger age and shorter time since first metastasis. Clinical Trial Registration: PRECONNECT (EudraCT Number: 2016-002311-18 ) and TALLISUR (EudraCT-Number: 2017-000292-83 ).","PeriodicalId":43638,"journal":{"name":"Colorectal Cancer","volume":null,"pages":null},"PeriodicalIF":4.2,"publicationDate":"2023-08-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41902939","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Colorectal cancer incidence and mortality: trends from the Pennsylvania Cancer Registry across three decades 大肠癌癌症发病率和死亡率：宾夕法尼亚癌症登记处三十年来的趋势
IF 4.2
Colorectal Cancer Pub Date : 2023-07-25 DOI: 10.2217/crc-2022-0011
Jonathan T Pham, W. Wong, Vonn Walter, J. Scow, M. Deutsch, A. Kulaylat
{"title":"Colorectal cancer incidence and mortality: trends from the Pennsylvania Cancer Registry across three decades","authors":"Jonathan T Pham, W. Wong, Vonn Walter, J. Scow, M. Deutsch, A. Kulaylat","doi":"10.2217/crc-2022-0011","DOIUrl":"https://doi.org/10.2217/crc-2022-0011","url":null,"abstract":"Aim: This study aims to examine trends in incidence and mortality of colorectal cancer (CRC) using a state-wide registry, focusing on race, age, and rurality. Methods: From 1990 to 2019, CRC age-adjusted incidence and mortality were examined through the Pennsylvania Cancer Registry using Joinpoint Regression to model average annual percent changes (AAPC). Results: In Pennsylvania, there was a decline in incidence (AAPC -1.7) and mortality (AAPC -2.5), consistent regardless of race or cancer stage, with an inflection in the 2000s demonstrating greater rate of decrease. Conversely, patients under 50 saw rising CRC incidence (AAPC 1.8). Rural counties showed higher mortality than urban counties. Conclusion: Across Pennsylvania, the incidence and mortality rates of CRC have decreased over the past three decades, apart from patients under 50.","PeriodicalId":43638,"journal":{"name":"Colorectal Cancer","volume":null,"pages":null},"PeriodicalIF":4.2,"publicationDate":"2023-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45602422","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exosome-derived miRNAs regulate macrophage-colorectal cancer cell cross-talk during aggressive tumor development 外源性miRNA在侵袭性肿瘤发展过程中调节巨噬细胞与癌症细胞的串扰
IF 4.2
Colorectal Cancer Pub Date : 2023-03-15 DOI: 10.2217/crc-2022-0012
Khandu Wadhonkar, Neha Singh, F. Heralde, S. P. Parihar, N. Hirani, M. Baig
{"title":"Exosome-derived miRNAs regulate macrophage-colorectal cancer cell cross-talk during aggressive tumor development","authors":"Khandu Wadhonkar, Neha Singh, F. Heralde, S. P. Parihar, N. Hirani, M. Baig","doi":"10.2217/crc-2022-0012","DOIUrl":"https://doi.org/10.2217/crc-2022-0012","url":null,"abstract":"Colorectal cancer is one of the leading causes of death worldwide. Its incidence and mortality have significantly increased during the past few years. Colorectal cancer cells cross-talk with other cells through exosomes in their tumor microenvironment. The miRNAs containing exosomes are responsible for tumor growth, invasion, and metastasis. Multiple studies have shown that exosomal miRNAs are key players in the crosstalk between cancerous, immune, and stromal cells during colorectal cancer development. They help in the establishment of the tumorigenic microenvironment by reprogramming macrophages towards a pro-tumorigenic phenotype. In this review, we discussed various exosomal miRNAs derived both from colorectal cancer cells and macrophages that promote or inhibit cancer aggression. We also discussed various miRNA-based therapeutic approaches to inhibit cancer progression.","PeriodicalId":43638,"journal":{"name":"Colorectal Cancer","volume":null,"pages":null},"PeriodicalIF":4.2,"publicationDate":"2023-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47345482","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Sequenced treatment after regorafenib and survival in metastatic colorectal cancer: a qualitative clinical review 瑞非尼后的序列治疗和转移性结直肠癌的生存:一项定性临床回顾
IF 4.2
Colorectal Cancer Pub Date : 2021-03-01 DOI: 10.2217/crc-2022-0006
S. Babajanyan, Megan Pollack, Sarah Castelo, A. Kavati, T. Bekaii-Saab
{"title":"Sequenced treatment after regorafenib and survival in metastatic colorectal cancer: a qualitative clinical review","authors":"S. Babajanyan, Megan Pollack, Sarah Castelo, A. Kavati, T. Bekaii-Saab","doi":"10.2217/crc-2022-0006","DOIUrl":"https://doi.org/10.2217/crc-2022-0006","url":null,"abstract":"There is limited evidence-based guidance regarding treatment sequencing and outcomes following regorafenib in patients with refractory metastatic colorectal cancer (mCRC). A targeted literature review was conducted to identify studies with clinical outcomes associated with regorafenib therapy and subsequent treatment following regorafenib therapy. The median overall survival range of the nine studies with sequenced-based survival data was 2.1–19.3 months for regorafenib prior to subsequent therapy in refractory mCRC. Safety outcomes in patients treated with regorafenib prior to other therapies in mCRC were generally comparable to reported adverse events in clinical trials for subsequent agents. Data from this review demonstrate a potential correlation between survival and the use of regorafenib prior to subsequent chemotherapy or targeted therapy in patients with refractory mCRC.","PeriodicalId":43638,"journal":{"name":"Colorectal Cancer","volume":null,"pages":null},"PeriodicalIF":4.2,"publicationDate":"2021-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44233891","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of Magnetic Resonance Imaging in Patients with Rectal Cancer 磁共振成像在癌症直肠癌患者中的作用
IF 4.2
Colorectal Cancer Pub Date : 2020-12-07 DOI: 10.5772/intechopen.94868
T. Teneva, A. Zlatarov, R. Grigorov
{"title":"Role of Magnetic Resonance Imaging in Patients with Rectal Cancer","authors":"T. Teneva, A. Zlatarov, R. Grigorov","doi":"10.5772/intechopen.94868","DOIUrl":"https://doi.org/10.5772/intechopen.94868","url":null,"abstract":"In a chapter about rectal cancer there is content about rectal anatomy in relation to magnet-resonanse imaging and TME- surgery (total mesorectal excision). Secondly there is content about imaging methods used in diagnosis and follow-up of rectal cancer. Very important topic is concerning the novel imaging strategies in surgical and radiotherapy planning in the era of individual oncologic approach to the patient. At last there is detailed desctiption and metaanalysis of imaging strategies concerning neoadjuvant and adjuvant radiotherapy and chemotherapy for rectal cancer patients. All imaging markers correspond to substantial oncologic parameters such as survival rates. The connecting bridge is magnet-resonance imaging.","PeriodicalId":43638,"journal":{"name":"Colorectal Cancer","volume":null,"pages":null},"PeriodicalIF":4.2,"publicationDate":"2020-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48255327","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信